1. Home
  2. FRMM vs NRXS Comparison

FRMM vs NRXS Comparison

Compare FRMM & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FRMM

Forum Markets Incorporated Common Stock

N/A

Current Price

$4.51

Market Cap

65.8M

Sector

Health Care

ML Signal

N/A

Logo Neuraxis Inc.

NRXS

Neuraxis Inc.

HOLD

Current Price

$7.43

Market Cap

78.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRMM
NRXS
Founded
N/A
2011
Country
United States
United States
Employees
2
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.8M
78.9M
IPO Year
2017
2023

Fundamental Metrics

Financial Performance
Metric
FRMM
NRXS
Price
$4.51
$7.43
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$13.00
AVG Volume (30 Days)
511.2K
177.3K
Earning Date
05-26-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
22.13
EPS
N/A
N/A
Revenue
N/A
$3,569,282.00
Revenue This Year
$183.55
$172.91
Revenue Next Year
$166.48
$115.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.89
52 Week Low
$1.76
$2.20
52 Week High
$5.87
$9.33

Technical Indicators

Market Signals
Indicator
FRMM
NRXS
Relative Strength Index (RSI) 53.24 44.43
Support Level $4.25 $6.80
Resistance Level $5.55 $8.03
Average True Range (ATR) 0.54 0.63
MACD -0.09 -0.16
Stochastic Oscillator 46.12 8.97

Price Performance

Historical Comparison
FRMM
NRXS

About FRMM Forum Markets Incorporated Common Stock

Forum Markets Inc is a financial technology company focused on developing infrastructure that supports the origination, financing, and distribution of RWAs through blockchain-enabled capital markets. The company's business approach is centered on integrating traditional financial asset markets with blockchain-based infrastructure to enable the tokenization of income-generating real-world assets such as consumer credit, equipment finance assets, and other contractual cash-flow streams. It utilizes blockchain infrastructure, including Ethereum and related Layer-2 scaling protocols, to support the issuance, management, and potential secondary trading of tokenized financial instruments.

About NRXS Neuraxis Inc.

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Share on Social Networks: